Get started
Author

Dick Johan van Spronsen

Observed names: D J Van Spronsen, D. J. Van Spronsen, D. J. van Spronsen, D.J. van Spronsen, Dick Johan Van Spronsen
Observed institutions: University Medical Center Groningen, Radboud University Nijmegen, Catharina Ziekenhuis, Medisch Spectrum Twente, Radboud University Medical Center, Canisius-Wilhelmina Ziekenhuis
ORCID: 0000-0003-1397-0236
Observed ORCID: 0000-0003-1397-0236
OpenAlex ID: A5090109552
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
2018 · Annemieke Cats, Edwin P M Jansen, et al. · The Lancet Oncology · 565
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
2020 · Alessandro Leal, Nicole C. T. van Grieken, et al. · Nature Communications · 242
PDF
Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996
1999 · D. J. van Spronsen, M. L. G. Janssen-Heijnen, et al. · Annals of Hematology · 102
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
2020 · Simone de Vries, Michael Schaapveld, et al. · JNCI Journal of the National Cancer Institute · 101
Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study
2011 · I.M.E Desar, E.G.W. ter Voert, et al. · Cancer Imaging · 41
PDF
Multimodality Imaging to Predict Response to Systemic Treatment in Patients with Advanced Colorectal Cancer
2015 · Linda Heijmen, Edwin E. G. W. ter Voert, et al. · PLoS ONE · 37
PDF
Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma
2022 · Simone de Vries, Miriam L. Haaksma, et al. · Journal of Clinical Oncology · 28
PDF
Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial
2021 · Daniëlle E. J. Starreveld, Laurien A. Daniels, et al. · Cancers · 26
PDF
Actual prognosis during follow-up of survivors of B-cell non-Hodgkin lymphoma in the Netherlands
2013 · S. A. M. van de Schans, L. N. van Steenbergen, et al. · Haematologica · 24
PDF
Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
2024 · Y.M. Geurts, S.I.M. Neppelenbroek, et al. · ESMO Open · 13
PDF
Oncology professionals’ perspectives towards cardiac surveillance in breast cancer patients with high cardiotoxicity risk: A qualitative study
2021 · Yvonne Koop, Laura Dobbe, et al. · PLoS ONE · 13
PDF
Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes
2019 · Nanon Labrie, Sandra van Dulmen, et al. · JMIR Research Protocols · 12
Sustained high levels of serum HHV-8 DNA years before multicentric Castlemanʼs disease despite full suppression of HIV with highly active antiretroviral therapy
2003 · Rianne Baatenburg de Jong, Philip M Kluin, et al. · AIDS · 9
Circulating tumor DNA dynamics in resectable gastric cancer.
2018 · Alessandro Leal, Nicole C.T. van Grieken, et al. · Journal of Clinical Oncology · 2
Common variable immunodeficiency in a family.
1992 · D J Van Spronsen, M Kerbert-Dreteler, et al. · PubMed · 2
Treatment-specific risk of second malignancies in five-year survivors of diffuse large B-cell lymphoma.
2021 · Yvonne M. Geurts, Suzanne I.M. Neppelenbroek, et al. · Journal of Clinical Oncology · 1
Non-Hodgkin's lymphoma and diabetes mellitus: reciprocal influence on treatment and outcome
2008 · T.T. van Herpt, S.A. van de Schans, et al. · Critical Reviews in Oncology/Hematology · 1
Works count: 18
Citation count: 1,321
H-index: 12
I10-index: 13
Year
Topic
Type